CORI Corium International Inc.

8.9
+0.07  (+1%)
Previous Close 8.83
Open 8.9
Price To Book 8.9
Market Cap 321646427
Shares 36,140,048
Volume 696,378
Short Ratio 10.33
Av. Daily Volume 254,294

SEC filingsSee all SEC filings

  1. S-3 - Registration statement under Securities Act of 1933 18886589
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 18832571
  3. 8-K - Current report 18830664
  4. 8-K - Current report 18715395
  5. 8-K - Current report 18702645

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Pilot bioequivalence data released May 11, 2017. NDA filing due 1Q 2019.
Corplex Donepezil
Alzheimer's disease
Phase 2a data released July 2015
MicroCor PTH
Osteoporosis
Additional Phase 3 required following rejection of NDA. Trial is ongoing by partner Agile
AG200-15
Contraceptive

SEC Filings

  1. S-3 - Registration statement under Securities Act of 1933 18886589
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 18832571
  3. 8-K - Current report 18830664
  4. 8-K - Current report 18715395
  5. 8-K - Current report 18702645
  6. 8-K - Current report 18694391
  7. SC 13G - Statement of acquisition of beneficial ownership by individuals 18692715
  8. 8-K - Current report 18666087
  9. SC 13G - Statement of acquisition of beneficial ownership by individuals 18664694
  10. 8-K - Current report 18654881